• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺切除术后,离体正中隆起中血管加压素与促肾上腺皮质激素释放因子的主要释放情况

Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy.

作者信息

Holmes M C, Antoni F A, Catt K J, Aguilera G

出版信息

Neuroendocrinology. 1986;43(2):245-51. doi: 10.1159/000124533.

DOI:10.1159/000124533
PMID:3487744
Abstract

In an in vitro system, we have demonstrated concomitant release of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) from the median eminence (ME) of normal and adrenalectomized rats. The ME were incubated in a Krebs-Ringer bicarbonate medium, CRF and AVP released into the medium were measured by radioimmunoassay. The release of both neuropeptides was stimulated by increasing concentrations of potassium (28-56 mM) in the incubation medium, or by addition of veratridine (5-20 microM). In both cases the release process was dependent on the presence of calcium in the incubation medium. Interestingly, potassium-induced release was found to be relatively insensitive to calcium channel antagonists that are potent inhibitors in smooth and cardiac muscle. The sodium channel antagonist, tetrodotoxin (1 microM), completely blocked the effect of veratridine, while no change was seen in the response to potassium. Adrenalectomy increased the ratio of AVP:CRF release from 2:1 in ME removed from sham-operated rats to 8:1 in ME from the adrenalectomized group. We suggest that this ratio of AVP:CRF release may also pertain in vivo, and that AVP could be the predominant corticotropic stimulus in adrenalectomized rats.

摘要

在体外系统中,我们已证明正常大鼠和肾上腺切除大鼠的正中隆起(ME)可同时释放促肾上腺皮质激素释放因子(CRF)和精氨酸加压素(AVP)。将ME置于 Krebs-Ringer 碳酸氢盐培养基中孵育,采用放射免疫分析法测定释放到培养基中的CRF和AVP。通过增加孵育培养基中钾的浓度(28 - 56 mM)或添加藜芦碱(5 - 20 μM)来刺激这两种神经肽的释放。在这两种情况下,释放过程均依赖于孵育培养基中钙的存在。有趣的是,发现钾诱导的释放对钙通道拮抗剂相对不敏感,而钙通道拮抗剂在平滑肌和心肌中是有效的抑制剂。钠通道拮抗剂河豚毒素(1 μM)完全阻断了藜芦碱的作用,而对钾的反应未见变化。肾上腺切除术使AVP:CRF释放的比例从假手术大鼠的ME中的2:1增加到肾上腺切除组的ME中的8:1。我们认为,AVP:CRF释放的这一比例在体内可能也成立,并且AVP可能是肾上腺切除大鼠中主要的促肾上腺皮质激素刺激物。

相似文献

1
Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy.肾上腺切除术后,离体正中隆起中血管加压素与促肾上腺皮质激素释放因子的主要释放情况
Neuroendocrinology. 1986;43(2):245-51. doi: 10.1159/000124533.
2
Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.双侧肾上腺切除术后下丘脑 - 促肾上腺皮质激素轴的变化:糖皮质激素作用于正中隆起部位的证据。
Neuroendocrinology. 1991 Feb;53(2):160-70. doi: 10.1159/000125713.
3
Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.去肾上腺及地塞米松处理大鼠体内的血管加压素与促肾上腺皮质激素释放因子-促肾上腺皮质激素
Neuroendocrinology. 1981 Feb;32(2):87-91. doi: 10.1159/000123136.
4
Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.药物性肾上腺切除术后促肾上腺皮质激素释放因子、精氨酸加压素和催产素的垂体门脉血浆水平、正中隆起含量及免疫组化染色
Endocrinology. 1987 Apr;120(4):1361-9. doi: 10.1210/endo-120-4-1361.
5
Vasopressin-containing and vasopressin-deficient subpopulations of corticotropin-releasing factor axons are differentially affected by adrenalectomy.含血管加压素和缺乏血管加压素的促肾上腺皮质激素释放因子轴突亚群受肾上腺切除术的影响不同。
Endocrinology. 1987 May;120(5):2180-2. doi: 10.1210/endo-120-5-2180.
6
Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats.
Neuroendocrinology. 1991 Feb;53(2):150-9. doi: 10.1159/000125712.
7
In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
Life Sci. 1985 Oct 21;37(16):1499-505. doi: 10.1016/0024-3205(85)90181-x.
8
Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats.在正常大鼠中,血管加压素共存于正中隆起外侧区促肾上腺皮质激素释放因子轴突的一半之中。
Neuroendocrinology. 1987 May;45(5):420-4. doi: 10.1159/000124768.
9
Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines.
Endocrinology. 1981 Sep;109(3):813-7. doi: 10.1210/endo-109-3-813.
10
Involvement of vasopressin in the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy.肾上腺切除术后血管加压素参与垂体促肾上腺皮质激素释放因子受体的下调。
Endocrinology. 1987 Dec;121(6):2093-8. doi: 10.1210/endo-121-6-2093.

引用本文的文献

1
Magnocellular Vasopressin and the Mechanism of "Glucocorticoid Escape".大细胞血管升压素与“糖皮质激素逃逸”机制
Front Endocrinol (Lausanne). 2019 Jun 26;10:422. doi: 10.3389/fendo.2019.00422. eCollection 2019.
2
Gender-dependent characteristics of the hypothalamo-corticotrope axis function in glucocorticoid-replete and glucocorticoid-depleted rats.糖皮质激素充足和糖皮质激素缺乏大鼠下丘脑 - 促肾上腺皮质激素轴功能的性别依赖性特征
J Endocrinol Invest. 1998 Dec;21(11):737-43. doi: 10.1007/BF03348038.
3
Sex difference in glucocorticoid regulation of vasopressin mRNA in the paraventricular hypothalamic nucleus.
下丘脑室旁核中糖皮质激素对血管加压素mRNA调节的性别差异。
Cell Mol Neurobiol. 1997 Dec;17(6):671-86. doi: 10.1023/a:1022538120627.
4
Intragranular colocalization of arginine vasopressin and methionine-enkephalin-octapeptide in CRF-axons in the rat median eminence.大鼠正中隆起中促肾上腺皮质激素释放因子轴突内精氨酸加压素与甲硫氨酸脑啡肽八肽的颗粒内共定位
Cell Tissue Res. 1987 Sep;249(3):497-507. doi: 10.1007/BF00217321.
5
Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.肾上腺切除术和糖皮质激素对大鼠垂体门脉血中促肾上腺皮质激素释放因子-41、血管加压素和催产素的影响。
J Physiol. 1988 Jul;401:329-45. doi: 10.1113/jphysiol.1988.sp017165.